176 related articles for article (PubMed ID: 30737278)
21. Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics.
De Feo CJ; Wang W; Hsieh ML; Zhuang M; Vassell R; Weiss CD
Retrovirology; 2014 Oct; 11():86. PubMed ID: 25274545
[TBL] [Abstract][Full Text] [Related]
22. Role for the terminal clasp of HIV-1 gp41 glycoprotein in the initiation of membrane fusion.
Lay CS; Ludlow LE; Stapleton D; Bellamy-McIntyre AK; Ramsland PA; Drummer HE; Poumbourios P
J Biol Chem; 2011 Dec; 286(48):41331-41343. PubMed ID: 21976663
[TBL] [Abstract][Full Text] [Related]
23. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.
Wyss S; Dimitrov AS; Baribaud F; Edwards TG; Blumenthal R; Hoxie JA
J Virol; 2005 Oct; 79(19):12231-41. PubMed ID: 16160149
[TBL] [Abstract][Full Text] [Related]
24. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.
Chabot DJ; Zhang PF; Quinnan GV; Broder CC
J Virol; 1999 Aug; 73(8):6598-609. PubMed ID: 10400757
[TBL] [Abstract][Full Text] [Related]
25. Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion.
Melikyan GB; Egelhofer M; von Laer D
J Virol; 2006 Apr; 80(7):3249-58. PubMed ID: 16537592
[TBL] [Abstract][Full Text] [Related]
26. Mutations of Glu560 within HIV-1 Envelope Glycoprotein N-terminal heptad repeat region contribute to resistance to peptide inhibitors of virus entry.
Yuan C; Wang JY; Zhao HJ; Li Y; Li D; Ling H; Zhuang M
Retrovirology; 2019 Dec; 16(1):36. PubMed ID: 31796053
[TBL] [Abstract][Full Text] [Related]
27. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
[TBL] [Abstract][Full Text] [Related]
28. Hydrophobic mutations in buried polar residues enhance HIV-1 gp41 N-terminal heptad repeat-C-terminal heptad repeat interactions and C-peptides' anti-HIV activity.
Zheng B; Wang K; Lu L; Yu F; Cheng M; Jiang S; Liu K; Cai L
AIDS; 2014 Jun; 28(9):1251-60. PubMed ID: 24625369
[TBL] [Abstract][Full Text] [Related]
29. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
[TBL] [Abstract][Full Text] [Related]
30. Genetic Pathway of HIV-1 Resistance to Novel Fusion Inhibitors Targeting the Gp41 Pocket.
Su Y; Chong H; Xiong S; Qiao Y; Qiu Z; He Y
J Virol; 2015 Dec; 89(24):12467-79. PubMed ID: 26446597
[TBL] [Abstract][Full Text] [Related]
31. The fusion activity of HIV-1 gp41 depends on interhelical interactions.
Suntoke TR; Chan DC
J Biol Chem; 2005 May; 280(20):19852-7. PubMed ID: 15772068
[TBL] [Abstract][Full Text] [Related]
32. The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.
Abrahamyan LG; Mkrtchyan SR; Binley J; Lu M; Melikyan GB; Cohen FS
J Virol; 2005 Jan; 79(1):106-15. PubMed ID: 15596806
[TBL] [Abstract][Full Text] [Related]
33. Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1.
Merat R; Raoul H; Leste-Lasserre T; Sonigo P; Pancino G
J Virol; 1999 Jul; 73(7):5698-706. PubMed ID: 10364320
[TBL] [Abstract][Full Text] [Related]
34. Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41.
Ashkenazi A; Viard M; Wexler-Cohen Y; Blumenthal R; Shai Y
FASEB J; 2011 Jul; 25(7):2156-66. PubMed ID: 21429941
[TBL] [Abstract][Full Text] [Related]
35. The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.
Day JR; Münk C; Guatelli JC
J Virol; 2004 Feb; 78(3):1069-79. PubMed ID: 14722262
[TBL] [Abstract][Full Text] [Related]
36. Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins.
Zhang SM; Jejcic A; Tam JP; Vahlne A
PLoS One; 2015; 10(7):e0134851. PubMed ID: 26230322
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells.
Denizot M; Varbanov M; Espert L; Robert-Hebmann V; Sagnier S; Garcia E; Curriu M; Mamoun R; Blanco J; Biard-Piechaczyk M
Autophagy; 2008 Nov; 4(8):998-1008. PubMed ID: 18818518
[TBL] [Abstract][Full Text] [Related]
38. The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors.
Zhu Y; Ding X; Yu D; Chong H; He Y
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619552
[TBL] [Abstract][Full Text] [Related]
39. Efficient Fusion at Neutral pH by Human Immunodeficiency Virus gp41 Trimers Containing the Fusion Peptide and Transmembrane Domains.
Liang S; Ratnayake PU; Keinath C; Jia L; Wolfe R; Ranaweera A; Weliky DP
Biochemistry; 2018 Feb; 57(7):1219-1235. PubMed ID: 29345922
[TBL] [Abstract][Full Text] [Related]
40. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
Murakami T; Ablan S; Freed EO; Tanaka Y
J Virol; 2004 Jan; 78(2):1026-31. PubMed ID: 14694135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
